Cellular Suppression Flashcards

1
Q

Cyclosporine

A
  1. Class/MOA: Calcineurin inhibitors: prevent transcription of IL-2 leading to decreased T cell activation (binds cyclophilin –> NFAT not dephosphorylated –> no transcription)
  2. Kinetics: Poor and variable bioavailability, narrow therapeutic range, metabolized by CYP3A4
  3. SE: Renal toxicity, HTN, hyperglycemia/hyperlipidemia, CNS tremor, gingival hyperplasia
  4. CI: watch out with CYP inducers and inhibitors!
  5. Uses: prevent rejection and maintenance after transplant, AI diseases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Tacrolimus

A
  1. MOA: calcineurin inhibitor, prevents transcription of IL-2 leading to decreased T cell activation (binds FKBP)
  2. Kinetics: IV/Oral/topical. Must be taken on empty stomach as food interferes w/absorption. Narrow therapeutic range, metabolized by CYP3A4.
  3. SE: more tolerable than cyclosporine, SE are the same just lessened: Renal toxicity, HTN, hyperglycemia, CNS effects, insomnia
  4. CI: watch out for CYP inducers/inhibitors. Caution with ACE/ARBs, don’t combine with aminoglycosides
  5. Uses: Prevent rejection especially with liver, kidney, and heart. Cream for atopic dermatitis.
  6. Other: long term use increases opportunistic infections and neoplasms (esp skin cancer)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pimecrolimus

A
  1. Like tacrolimus, binds FKBP-12
  2. Cream for atopic dermatitis, does not thin skin/cause atrophy like steroids
  3. SE: skin irritation or burning
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Belatacept

A
  1. MOA: Blocks costimulatory molecules of APCs –> prevents T-cell stimulation and proliferation.
  2. Injection only, must be combined with mycophenolate mofetil
  3. SE: better CV profile and less risk of diabetes than cyclosporine. GI and infusion related SE are most common.
  4. Used in kidney transplants only if EBV positive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sirolimus

A
  1. MOA: blocks response of T-cells to IL-2, inhibits B cell proliferation
  2. Oral absorption (significantly reduced by food), CYP3A4 metabolism
  3. SE: no renal toxicity, increases cholesterol and triglycerides, profound myelosuppression (anemia/leukopenia), impair wound healing, possible hepatotoxicity.
  4. Uses: Kidney transplant, prevent graft v. host in stem cell.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mycophenolate Mofetil

A
  1. MOA: inhibits inosine monophosphate dehydrogenase –> prevents de novo purine synthesis (specific to T/B cells since other cells have salvage), suppresses lymphocyte proliferation and ab production by B cells.
  2. Kinetics: well absorbed orally, 90% renal excretion, prodrug that is converted to mycophenolic acid in vivo
  3. SE: GI most common, often causes a rash (limits use)
  4. CI: PREGNANCY!!! women of child bearing age must use contraception
  5. Uses: combined with cyclosporine/tacrolimus and glucocorticoids to prevent rejection.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Azathiprine

A
  1. MOA: converted to 6-mercaptopurine in vivo, inhibits de novo purine synthesis, blocks transcription and cell proliferation. Many lymphocyte actions inhibited, inhibits delayed hypersensitivity and cellular cytotoxicity after transplant.
  2. Kinetics: metabolized by xanthine oxidase
  3. SE: Bone marrow suppression, inc infections (esp herpes), N/V/D, liver toxicity (elevated enzymes), teratogenic, alopecia, skin rashes
  4. Uses: Used as adjunct with tacrolimus/cyclosporine and prednisone to prevent transplant rejection, tx glomerulonephritis of SLE, severe RA
  5. CI: Pregnancy, must reduce dose greatly if pt is on allopurinol (xanthine oxidase inhibitor).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Leflonimide

A
  1. MOA: Inhibits dihydroorotate dehydrogenase –> dec de novo pyrimidine synthesis –> decreased lymphocyte activation
  2. SE: Liver and renal toxicity, teratogenic
  3. CI: pregnancy
  4. Uses: RA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cyclophosphamide

A
  1. MOA: direct effect on T and B lymphocytes, especially those which have undergone antigenic differentiation and division.
  2. Kinetics: CYP450 activation
  3. SE: Hemorrhagic cystitis (prevent w/ hydration and MESNA), N/V, BM suppression, bladder fibrosis and carcinoma, alopecia, teratogenic
  4. CI: Pregnancy
  5. Uses: Organ transplant (can inhibit established immune response, good for rescue). Severe MS, RA, SLE. BM transplants, anti-neoplastic.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Prednisone

A
  1. Steroid, used for general immunosuppression
  2. depress macrophage response, lysis of lymphocytes, decreases cytokine production and responses, inhibits T-cell proliferation, anti-inflammatory
  3. SE: Cushings syndrome, immunosuppression, osteoporosis, suppress HPA axis
  4. Uses: minimize allergic responses to anti-lymphocytic globulin/monoclonal ab. Transplants both to prevent and treat acute rejection, immunosuppressive for all allergies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Methotrexate

A
  1. MOA: inhibits dihydrofolate reductase inhibitor –> T-cell and macrophage inhibition (inhibits folate-dependent steps in purine syn).
  2. Kinetics: well absorbed orally, renal excreted.
  3. SE: BM suppression, alopecia, hepatotoxicity, teratogenic
  4. CI: Pregnancy
  5. Uses: immunosuppression in organ transplants, psoriasis, RA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Thalidomide

A
  1. MOA: Decreases TNF-alpha and IL-6 –> shifts T-cell response to TH2 subset, decreases activity of neutrophils, enhances cell mediated immunity by T cells
  2. Kinetics: Oral admin
  3. SE: TERATOGENIC!!!!!!!, inc risk of DVT, sedation, neutropenia
  4. CI: PREGNANCY!!!!!
  5. Uses: Prevents graft v host, acute myelogenous leukemia. Tx of multiple myeloma, leprosy, some cancers and causes weight gain in AIDS wasting.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly